This site is intended for Healthcare professionals only.
×

Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore


Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore

NEW Delhi: Bliss GVS Pharma on has reported a 22 per cent increase in consolidated profit to Rs 41.45 crore in the second quarter ended September 30, 2018. Bliss GVS Pharma had posted a profit of Rs 33.98 crore in the same period a year ago.

Bliss GVS Pharma is an Indian pharmaceutical and company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others

Total income of the company increased by 4.8 per cent to Rs 253.3 crore from Rs 241.7 crore during the period under review.



Source: PTI
0 comment(s) on Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted